T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Sun Life Financial
SLF
$44.4B
| $295M | 0.04% |
7,097,374
+92,849
| +1% | +$3.73M |
|
377
Ultragenyx Pharmaceutical
RARE
$2.63B
| $293M | 0.04% |
4,611,939
+1,110,316
| +32% | +$70.7M |
|
378
Ventas
VTR
$45.6B
| $292M | 0.04% |
4,272,708
+950,397
| +29% | +$60.6M |
|
379
Monro
MNRO
$361M
| $290M | 0.04% |
3,395,833
-6,605
| -0.2% | -$551K |
|
380
Quaker Houghton
KWR
$2.93B
| $290M | 0.04% |
1,426,977
+380,431
| +36% | +$77.3M |
|
381
Darden Restaurants
DRI
$25.5B
| $287M | 0.04% |
2,357,328
-28,792
| -1% | -$3.43M |
|
|
HR
382
DELISTED
Healthcare Realty Trust Incorporated
HR
| $286M | 0.04% |
9,117,172
+473,389
| +5% | +$15M |
|
383
Neurocrine Biosciences
NBIX
$16B
| $286M | 0.04% |
3,381,769
-94,381
| -3% | -$7.75M |
|
384
Diamondback Energy
FANG
$56.4B
| $284M | 0.04% |
2,605,292
-13,828
| -0.5% | -$1.44M |
|
385
Tesla
TSLA
$1.29T
| $284M | 0.04% |
19,050,165
-6,061,215
| -24% | -$94.3M |
|
386
Adobe
ADBE
$102B
| $282M | 0.04% |
958,627
-3,162
| -0.3% | -$878K |
|
387
ConocoPhillips
COP
$152B
| $282M | 0.04% |
4,624,735
-3,104,087
| -40% | -$193M |
|
|
ETRN
388
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $282M | 0.04% |
14,305,088
-949,498
| -6% | -$19.7M |
|
389
KLA
KLAC
$273B
| $281M | 0.04% |
23,775,930
+6,190,190
| +35% | +$71.6M |
|
|
WMGI
390
DELISTED
Wright Medical Group Inc
WMGI
| $281M | 0.04% |
9,416,562
-208,086
| -2% | -$6.35M |
|
391
Euronet Worldwide
EEFT
$2.63B
| $278M | 0.04% |
1,649,624
-578,215
| -26% | -$88.4M |
|
392
SLB Ltd
SLB
$78.5B
| $277M | 0.04% |
6,977,085
+94,751
| +1% | +$3.82M |
|
393
RTX Corp
RTX
$300B
| $276M | 0.04% |
3,366,460
-787,437
| -19% | -$65.8M |
|
394
C.H. Robinson
CHRW
$17.3B
| $275M | 0.04% |
3,264,674
+38,551
| +1% | +$3.24M |
|
395
Synchrony
SYF
$25.7B
| $272M | 0.04% |
7,835,364
-1,273,704
| -14% | -$43.2M |
|
396
Visteon
VC
$2.81B
| $272M | 0.04% |
4,635,289
+672,851
| +17% | +$41.1M |
|
397
SiteOne Landscape Supply
SITE
$4.24B
| $270M | 0.04% |
3,895,982
+106,931
| +3% | +$6.92M |
|
|
VIAB
398
DELISTED
Viacom Inc. Class B
VIAB
| $270M | 0.04% |
9,035,138
+90,081
| +1% | +$2.63M |
|
399
Starbucks
SBUX
$123B
| $269M | 0.04% |
3,211,459
-172,235
| -5% | -$13.5M |
|
400
Emerson Electric
EMR
$91.6B
| $269M | 0.04% |
4,026,376
-60,815
| -1% | -$4.07M |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.